Who
Angelos Papadimitriou
Director
Company insider
Files Form 4 as: Director, Cognex.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $461K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Feb 2023
- Last trade
- 23 Feb 2026
- Last filed
- 24 Feb 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $231K4,150 at $55.58 | filing |
| 23 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $231K4,150 at $55.58 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —2,537 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,537 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,537 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —2,537 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —8,324 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —8,324 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —8,324 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —8,324 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,817 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,817 at $0.00 | filing |
| 21 Feb 2025filed 24 Feb 2025 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,522 at $0.00 | filing |
| 21 Feb 2025filed 24 Feb 2025 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —1,522 at $0.00 | filing |
| 20 Feb 2025filed 24 Feb 2025 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,973 at $0.00 | filing |
| 20 Feb 2025filed 24 Feb 2025 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —6,973 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —8,324 at $0.00 | filing |
| 21 Feb 2024filed 22 Feb 2024 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,016 at $0.00 | filing |
| 21 Feb 2024filed 22 Feb 2024 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —1,016 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,973 at $0.00 | filing |
News
Barclays Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) StockCGNX · themarketsdaily.com · 12 Oct 2026Cognex (NASDAQ:CGNX) Stock Price Down 7.3% After Analyst DowngradeCGNX · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Angelos Papadimitriou; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.